Neko Health, a Stockholm, Sweden-based preventative healthcare technology company, has successfully raised €60 million in a Series A funding round.
The round was led by Lakestar, with participation from Atomico and General Catalyst. Klaus Hommels (Lakestar) and Niklas Zennström (Atomico) will join the company's board alongside the founders.
The funding will be used to accelerate Neko Health's expansion plans, invest in research and development, conduct clinical studies, and attract top talent.
Neko Health's vision is to create a healthcare system focused on preventive measures and early detection to help people maintain their health.
"Healthcare costs are spiraling out of control. We believe preventive health will be key to reversing this trend. Doctors today just don't have enough time or resources to focus on prevention. This leads to many health problems going unnoticed until they get really serious, causing a lot of pain and putting a massive strain on the healthcare system.” said Hjalmar Nilsonne, CEO and co-founder of Neko Health. “We've demonstrated that our unique approach to this problem resonates with people – that there's a genuine need and desire for this change. This strong demand is what's driving us to expand our horizons. To accelerate this, we're partnering with external investors for the first time. It's time to create the healthcare future we want, for ourselves, and for future generations.”
The company has developed a new concept for medical scanning technology, enabling broad and non-invasive collection of health data that is quick, convenient, and affordable. With over 70 sensors, the scan collects 50 million data points in minutes, allowing for the detection of small skin changes as minute as 0.2 millimeters.
The technology is designed to assist doctors in the early detection of various diseases, including skin conditions, skin cancer, cardiovascular disease, diabetes, and metabolic syndromes. While currently available only in Stockholm, the Neko Body Scan experience is set to expand to clinics across Europe.
Company: Neko Health AB
Raised: €60.0M
Round: Series A
Funding Month: July 2023
Lead Investors: Lakestar
Additional Investors: Atomico and General Catalyst
Company Website: https://www.nekohealth.com/
Software Category: AI-powered Preventative Healthcare Body Scanner
About the Company: Founded in 2018 by Hjalmar Nilsonne and Daniel Ek, Neko Health designs a medical technology using artificial intelligence and sensor technology to develop a healthcare system. It provides services such as body scans, skin scans, cardiovascular examinations, and more to detect and prevent serious illnesses. Neko Health is headquartered in Stockholm and also operates the Atrium Vårdcentral clinic in Kungsholmen. With the help of the latest sensor technology and AI, they believe that it is possible to create cheap and flexible examinations that can raise the quality of healthcare and focus on prevention.
Source: https://www.nekohealth.com/en/press-release-series-a